Back
Nutrison 800 Multi Fibre | Nutricia Adult Healthcare

Nutrison 800 Complete Multi Fibre

A nutritionally complete, high protein, lower energy, fibre enriched, ready-to-use enteral tube feed.
  1. Suitable as a sole source of nutrition.^
  2. 0.83kcal/ml: for patients requiring lower energy diets.1-3
  3. 55g protein (27%E) per 1000ml: to meet the protein requirements of patients with low energy requirements.
  4. Whey-dominant P4 protein blend: in line with international recommendations on protein quality/amino acid profile and for gastro intestinal tolerance benefits. 6-11
Download Product Factsheet
Link copied!
Indications

For the dietary management of:

  • Disease-related malnutrition.
  • Patients with reduced energy requirements (e.g. patients who are immobile and/or have a severe neurological disorder).
Important Notice
  • Not for parenteral use.
  • Not suitable for patients requiring a fibre free diet.
  • Not suitable for patients with galactosaemia.
  • Not suitable for patients with cow’s milk protein allergy.
  • Not suitable for infants under 1 year of age.
  • Use with caution in children aged 1-12 years of age.
  • Use with caution in individuals with a seafood allergy.
Direction for Use
  • Shake well before use.
  • Use at room temperature.
  • Handle aseptically to ensure product remains sterile.
  • Usage to be determined by a healthcare professional.
Storage
  • Store in a cool, dry place.
  • Once opened, store in the refrigerator.
  • Discard unused content after 24 hours.
Order Information

Contact Nutricia Customer Care 0800 688 747

Nutrison 800 Complete Multi Fibre  Product Code  Units per carton  Pharmacode 
1000ml OpTri bottle  132379  8  2572982 
Ingredients

Full ingredients list and nutritional information available on Factsheet.

Allergen & Cultural Information
  • Contains: cow’s milk protein, soy, fish oil.
  • Does not contain: wheat, egg, nuts*, lupins.
  • Halal certified.
  • No Kosher forbidden ingredients.
  • No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
  • Low lactose (lactose < 2g/100g).
References
  1. Dickerson RN et al. Measured energy expenditure of tube-fed patients with severe neurodevelopmental disabilities. J Am Coll Nutr. 1999 Feb;18(1):61-8.
  2. Dickerson RN et al. Energy requirements of non-ambulatory, tube-fed adult patients with cerebral palsy and chronic hypothermia. Nutrition. 2003 Sep;19(9):741-6.
  3. Dickerson RN et al. Validation of a new method for estimating resting energy expenditure of non-ambulatory tube-fed patients with severe neurodevelopmental disabilities. Nutrition. 2002 Jul-Aug;18(7-8):578-82.
  4. Hurt RT, McClave SA, Martindale RG, et al. Summary Points and Consensus Recommendations From the International Protein Summit. Nutrition in Clinical Practice. 2017;32:142S–151S.
  5. World Health Organization. Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. 2007; WHO technical report series ; no. 935.
  6. Kuyumcu S, Menne D, Curcic J, et al. Noncoagulating enteral formula can empty faster from the stomach: A double-blind, randomized crossover trial using magnetic resonance imaging. Journal of Parenteral and Enteral Nutrition. 2015;39:544-551.
  7. van den Braak CC, Klebach M, Abrahamse E, et al. A novel protein mixture containing vegetable proteins renders enteral nutrition products non-coagulating after in vitro gastric digestion. Clinical Nutrition. 2013;32:765-771.
  8. Klebach M, Hofman Z, Bluemel S, et al. Effect of protein type in enteral nutritionformulas on coagulation in the stomach in vivo: Post hoc analyses of a randomized controlled trial with MRI. Abstract presented at Clinical Nutrition Week, January 16–19; Austin, Tx. Journal of Parenteral and Enteral Nutrition. 2016;40:134(21).
  9. Luttikhold J, van Norren K, Rijna H, et al. Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial. Am J Clin Nutr. 2016;103:435–43.
  10. Abrahamse E, van der Lee S, van den Braak S, et al. Gastric non-coagulation of enteral tube feed yields faster gastric emptying of protein in a dynamic in vitro model. Abstract presented at 34th ESPEN Congress. Sept 8-11; Barcelona, Spain. Clinical Nutrition Supplements. 2012;7:PP239(119).
  11. Liu J, Klebach M, Abrahamse E, et al. Specific protein mixture reduces coagulation: An in vitro stomach model study mimicking a gastric condition in critically ill patients. Poster presented at 38th ESPEN Congress. 17-20 September; Copenhagen, Denmark. Clinical Nutrition. 2016;35:MON-P182 (S220).
Additional Information

^ In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5

 
# MF6 is a unique, patented blend of six soluble and insoluble fibres (soy polysaccharide, cellulose, resistant starch, gum arabic, oligofructose and inulin) reflecting the proportions of the different fibre types in a healthy diet.
 
* Peanut (Arachis hypogaea), Almond (Amygdalus communis L .), Hazelnut (Corylus avellana), Walnut (Juglans regia), Cashew (Anacardium occidentale), Pecan nut (Carya illinoiesis (Wangenh.) K. Koch), Brazil nut (Bertholletia excelsa), Pistachio nut (Pistacia vera), Macadamia nut and Queensland nut (Macadamia ternifolia), and products thereof.